Job for Scientist in Compendial Development Laboratory at USP | M.Pharm, M.Sc
The United States Pharmacopeia (USP) is a non–governmental, official public standards–setting authority for prescription and over–the–counter medicines and other healthcare products manufactured or sold in the United States. USP also sets widely recognized standards for food ingredients and dietary supplements. USP sets standards for the quality, purity, strength, and consistency of these products–critical to the public health. USP's standards are recognized and used in more than 130 countries around the globe. These standards have helped to ensure public health throughout the world for close to 200 years.
Post : Scientist I Compendial Development Laboratory
Panacea Biotec is a leading research based Health Management Company. We are engaged in research, development, manufacture & marketing of Vaccines, Bio-Pharmaceuticals and Pharmaceuticals (Rx & OTC) of international quality and Health Services. All Panacea Biotec plants are accredited by international agencies and they follow current Good Manufacturing Practices, as per WHO guidelines.Panacea Drugs Pvt. Ltd. was set up in the year 1984, with a commitment to make novel and innovative medicines affordable to the masses a dream of healthy India, and got listed in 1995 as Panacea Biotec Ltd. 
The Public Health Foundation of India (PHFI) is a not-for-profit public private initiative that has collaboratively evolved through consultations with multiple constituencies including Indian and international academia, state and central governments, multi & bi-lateral agencies and civil society groups. PHFI is a response to redress the limited institutional capacity in India for strengthening training, research and policy development in the area of Public Health. The PHFI focuses on broad dimensions of public health that encompass promotive, preventive and therapeutic services, many of which are frequently lost sight of in policy planning as well as in popular understanding.
Biocon is a research-driven, global healthcare company with a strong matrix of capabilities along the biopharmaceutical value chain. Focusing on unmet medical needs in cancer, diabetes and inflammatory diseases, it offers novel therapies on a platform of affordable innovation. Biocon together with group companies employs more than 2500 employees with approxmimately Rs 1,000 crore turnover and is expected to grow further during the current financial year.
The genesis of the ISHITA group in 1972 was the result of the entrepreneurial spirit of Mr. Jagdish Agrawal, who set up a reactive dye manufacturing unit in Ahmedabad. Buoyed by the growth of its first Venture, the group made its maiden foray in the pharma sector in 1981 by setting up a small Bulk drugs plant at Surendranagar in the state of Gujarat, to cater to the need of Pharma industry for Quality Products. The Bulk Drugs Industry at that point of time was highly dependent on costly imports and the growth was not easily achievable. But ‘ISHITA’ continued to achieve excellence in Quality of its products using innovative technology, and cost effective processes developed by in house R&D.Manufacturer of various Active Pharma Ingredients (bulk actives and their salts), drug intermediates, excipients and fine chemicals.
